CARsgen Therapeutics Holdings Limited
CRTHF
$0.76
$0.01351.81%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.52M | 3.50M | 2.30M | 2.31M | 437.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.52M | 3.50M | 2.30M | 2.31M | 437.80K |
| Cost of Revenue | 1.49M | 1.48M | 1.39M | 1.39M | 326.10K |
| Gross Profit | 2.03M | 2.02M | 912.60K | 917.10K | 111.60K |
| SG&A Expenses | 2.84M | 2.82M | 5.13M | 5.16M | 6.14M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 15.00K | 14.90K | 9.92M | 9.96M | -190.10K |
| Total Operating Expenses | 13.28M | 13.20M | 31.74M | 31.89M | 23.10M |
| Operating Income | -9.75M | -9.70M | -29.44M | -29.58M | -22.66M |
| Income Before Tax | -5.22M | -5.19M | -31.02M | -31.17M | -24.27M |
| Income Tax Expenses | -- | -- | 24.10K | 24.20K | -- |
| Earnings from Continuing Operations | -5.22M | -5.19M | -31.04M | -31.19M | -24.27M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.22M | -5.19M | -31.04M | -31.19M | -24.27M |
| EBIT | -9.75M | -9.70M | -29.44M | -29.58M | -22.66M |
| EBITDA | -7.50M | -7.46M | -27.39M | -27.52M | -20.20M |
| EPS Basic | -0.01 | -0.01 | -0.06 | -0.06 | -0.04 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.04 | -0.04 | -0.03 |
| EPS Diluted | -0.01 | -0.01 | -0.06 | -0.06 | -0.04 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.04 | -0.04 | -0.03 |
| Average Basic Shares Outstanding | 551.39M | 551.39M | 548.72M | 548.72M | 557.03M |
| Average Diluted Shares Outstanding | 551.39M | 551.39M | 548.72M | 548.72M | 557.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |